The IMAGIO consortium, coordinated by Philips, has received a EUR 24 million grant from the Innovative Health Initiative to advance research on less invasive cancer treatments for lung cancer, liver cancer, and soft tissue sarcomas. This initiative includes about 30 partners, featuring prominent European hospitals such as Leiden, Maastricht, Radboud, and Utrecht University Medical Centers in the Netherlands and the University Hospital of Cologne in Germany.

The consortium aims to improve clinical outcomes in interventional oncology by utilizing advanced imaging techniques like MRI, ultrasound, and CT to target cancer cells with minimal damage to healthy tissue. This approach seeks to reduce the need for major surgeries and decrease negative side effects from treatments.

Key projects include collaborations to enhance lung cancer diagnostics and treatments, improve liver cancer management through various imaging technologies, and develop innovative therapies for soft tissue sarcomas using MR-guided high-intensity focused ultrasound combined with new drug formulations. The consortium's multidisciplinary approach is expected to make significant strides in cancer care.